Vertex Pharmaceuticals Inc
SWB:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
SWB:VX1
|
US |
|
T
|
Tesla Inc
DUS:TL0
|
US |
|
Yangtze Optical Fibre and Cable Joint Stock Ltd Co
F:1YO
|
CN |
|
LiveOne Inc
F:3510
|
US |
|
S
|
Sands China Ltd
XBER:599A
|
MO |
|
N
|
Nordstrom Inc
XBER:NRD
|
US |
|
R
|
Ryde Group Ltd
AMEX:RYDE
|
SG |
|
F
|
First Western Financial Inc
F:33Q
|
US |
|
K
|
Krystal Biotech Inc
F:4KB
|
US |
|
O
|
Orange SA
SWB:FTE
|
FR |
|
T
|
Thai Union Feedmill PCL
SET:TFM
|
TH |
|
W
|
Wharf Real Estate Investment Company Ltd
OTC:WRFRF
|
HK |
|
B
|
Baidu Inc
F:B1C
|
CN |
|
Boeing Co
LSE:0BOE
|
US |
|
C
|
Cisco Systems Inc
BMV:CSCO
|
US |
|
C
|
Corning Inc
SWB:GLW
|
US |
|
D
|
Deutsche Telekom AG
DUS:DTE
|
DE |
|
T
|
thyssenkrupp nucera AG & Co KgaA
OTC:THYKF
|
DE |
|
N
|
Nokia Oyj
F:NOAA
|
FI |
Wall St Price Targets
VX1 Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VX1 is 492.01 EUR with a low forecast of 307.67 EUR and a high forecast of 595.85 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VX1's stock price target?
Price Target
492.01
EUR
According to Wall Street analysts, the average 1-year price target for VX1 is 492.01 EUR with a low forecast of 307.67 EUR and a high forecast of 595.85 EUR.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
14%
The compound annual growth rate for Net Income over the next 8 years is 14%.
